Glucagon · source year
4 selected, source-linked Glucagon records carrying a 1998 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
4 selected records.
1 represented type.
4 distinct public records.
Cited chronology
Regulatory
The Federal Register published proposed rule 98-29855, attributed to FDA and its parent HHS department, on 1998-11-12. Its official title is “Medical Devices; Exemption From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.
Source: Federal Register via GovInfo ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for NDA 020928 with status AP dated 1998-09-11, and names glucagon among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Regulatory
The official Drugs@FDA dataset lists original submission 1 for NDA 020918 with status AP dated 1998-06-22, and names glucagon hydrochloride among the application record's active ingredients.
Source: Drugs@FDA via openFDA ↗
Regulatory
The Federal Register published notice 98-2498, attributed to FDA and its parent HHS department, on 1998-02-02. Its official title is “Medical Devices; Exemptions From Premarket Notification and Reserved Devices; Class I,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.
Source: Federal Register via GovInfo ↗